| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |